Summary
The authors studied the effect of phthivazid on the synthesis of cholesterin in the organism of tuberculous patients. It was established that in the majority of patients (21 of the 24) the therapeutic doses of phthivazid decrease the cholesterin level from 143 mg% (before administration of phthivazid) to 123 mg%, on the average by the third day. With prolonged treatment by phthivazid (one month) the cholesterin level gradually approaches its initial value (but never exceeds it).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literature Cited
Iu.M. Ostrovskii, Zdravookhranenie Belorussii 5, 49–52 (1955).
R. Altschul, A. Hoffer and J. Stephen, Arch. Biochem., Biophys. 54, 2 (1955).
J.W. Conforth, Reys Pure and Appl. Chem. 4, 275–302 (1954).
S. Garattini, Boll. Soc. ital. biol. sper. 29, 11 (1953).
H.J. Hughes, Pharm. Exptl. Therap. 109, 4 (1953).
W. Johnson, Canad. J. Bioch. Physiol. 33, 107–111 (1955).
J. Rabinowitz and S. Gurin, J. Am. Chem. Soc. 76, 20 (1954).
D. Squadrito, Rif. med. 69, 37–41 (1955).
P. Weiksel, Beitr. Klin. Tuberk. 110, 3 (1953).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ostrovskii, I.M., Kagan, D.Z. & Iaroshevich, A.A. Phthivazid and cholesterin metabolism. Bull Exp Biol Med 45, 551–553 (1958). https://doi.org/10.1007/BF00784967
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00784967